Europe — EMA

Oxaliplatin Onkovis

Oxaliplatin, the active ingredient in Oxaliplatin Onkovis, is a platinum‑based chemotherapy agent presented as a sterile powder for intravenous infusion use.

Oxaliplatin

Request sourcing

Pack/s

What is Oxaliplatin?

Oxaliplatin, the active ingredient in Oxaliplatin Onkovis, is a platinum‑based chemotherapy agent presented as a sterile powder for intravenous infusion use. It treats colorectal cancer and other solid tumours in adult patients. GNH USA supplies Oxaliplatin Onkovis as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

GNH USA supplies Oxaliplatin Onkovis as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

What is Oxaliplatin used for?

Oxaliplatin Onkovis is a platinum‑based chemotherapy drug that acts on rapidly ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... .

- Colorectal cancer: Improves ... ... ... ... ... ... ... ... ... . - ... ... ... ... ... . - ... ... ... ... ... ... ... .

What are the side effects of Oxaliplatin?

… .... … … … …

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →